Indaptus Therapeutics is trading 7.97% up at $1.25, possibly reflecting firmer pre-market sentiment as Nasdaq futures rise 0.85%.
- A volatile stretch included a 46.81% surge on August 20, followed by subsequent declines.
- No fresh company-specific announcement was identified for August 25; second-quarter results were released August 13, while a substantial resale registration was filed August 17.